DNA Vaccines pp 83-89
Needle-Free Injection of DNA Vaccines: A Brief Overview and Methodology
The development of needle-free injection originally stemmed from a general apprehension of needle injections, disease transmission by accidental needle-sticks, and the need for effective mass immunization. Naked DNA vaccines, as attractive and universal as they appear, have not produced robust immune responses in test systems. However, proof of principle for DNA vaccines has been validated with a number of vaccine candidates in a variety of test systems, and the concept of DNA vaccines as a generic platform for vaccines still remains viable and attractive. Many avenues are being explored to enhance the immunogenicity of DNA vaccines. The easiest and most straightforward approach that can be quickly transitioned to a clinical trial setting is vaccine delivery by a needle-free jet injector. This approach has shown much potential in a number of cases and should become the lead method for enhancing DNA vaccines. This approach requires no additional development, and with an expanding market and willingness from jet injector manufacturers to produce prefilled syringes, the technique should become feasible for larger phase II/phase III trials.
Key WordsNeedle-free biojector DNA vaccine mouse primates
- 9.van Rooij, E. M, Haagmans, B. L., de Visser, Y. E., de Bruin, M. G., Boersma, W., and Bianchi, A. T. (1998) Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet. Immunol. Immunopathol. 66, 113–126.CrossRefPubMedGoogle Scholar
- 16.Raviprakash, K., Ewing, D., Simmons, M., et al. (2003) Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology 315, 345–352.CrossRefPubMedGoogle Scholar